Results 41 to 50 of about 9,080 (215)
Pulmonary fungal infections in patients with acute myeloid leukaemia: is it the time to revise the radiological diagnostic criteria? [PDF]
, 2016 The definition of pulmonary fungal infections (PFI) according to the EORTC-MSG criteria may lack diagnostic sensitivity due to the possible presentation of PFI with different radiological pictures.
Ascioglu +19 more
core +1 more source
Archives of Internal Medicine, 1999 Pulmonary mucormycosis is relatively uncommon but an important opportunistic fungal infection in immunocompromised persons. The literature on the subject is sparse. We describe a recent case and review the literature to delineate the clinical characteristics of this infection.
F Y, Lee, S B, Mossad, K A, Adal
openaire +2 more sources
Case 160: Pulmonary Mucormycosis [PDF]
Radiology, 2010 The radiologist can be instrumental in alerting the clinician to mucormycosis when the reversed halo sign is present.
Jonathan H, Chung +3 more
openaire +2 more sources
Can Intravenous Antifungal therapy be safely used in the Outpatient Parenteral Antimicrobial Therapy (OPAT) setting? [PDF]
, 2019 Outpatient parenteral antimicrobial therapy (OPAT) is an established treatment option for patients with a variety of infections who require a period of intravenous therapy, are clinically stable, and do not require continuous monitoring.
Kenny, Claire +2 more
core +2 more sources
Recognition and Clinical Presentation of Invasive Fungal Disease in Neonates and Children [PDF]
, 2017 AW and JK are supported by the Wellcome Trust Strategic Award (grant 097377) and the MRC Centre for Medical Mycology (grant MR/N006364/1) at the University of AberdeenPeer reviewedPublisher ...
King, Jill +4 more
core +1 more source
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 2019 Conditions, where the patient's immune system is compromised are the main risk factor for mucormycosis. Approximately 23% of the world's population is estimated to have a latent Mycobacterium tuberculosis infection and more than 10 million new cases were
Jiménez-Zarazúa O +6 more
doaj +1 more source
COVID-19-Associated Pulmonary Mucormycosis
Journal of Fungi, 2022 COVID-19-associated mucormycosis (CAM) emerged as an epidemic in certain parts of the world amidst the global COVID-19 pandemic. While rhino–orbital mucormycosis was well reported during the pandemic, in the absence of routine diagnostic facilities including lower airway sampling, pulmonary mucormycosis was probably under-recognized. In this review, we
Vidya Krishna +3 more
openaire +3 more sources
Journal of the Korean Society of RadiologyMucormycosis encompasses a range of fungal infections that can impact various organs. Although pulmonary mucormycosis is relatively rare, it poses a significant threat, particularly to individuals with compromised immune systems. Pulmonary mucormycosis
Hyo Ju Na +4 more
doaj +1 more source
Chronic Renal Failure Presenting for the First Time as Pulmonary Mucormycosis with a Fatal Outcome
Case Reports in Nephrology, 2015 Pulmonary mucormycosis is an uncommon, but important, opportunistic fungal pneumonia which is often diagnosed late. Renal failure as the predominant presenting feature is not common in mucormycosis.
B. Jayakrishnan +5 more
doaj +1 more source
A case report of pulmonary mucormycosis
APIK Journal of Internal Medicine, 2020 Pulmonary mucormycosis is a relatively rare pulmonary fungal disease which is difficult to diagnose and lacks effective treatment. The present study reports that the case of a 57-year-old patient who was treated successfully for pulmonary mucormycosis in
Surajsingh Ravindra Taur +2 more
doaj +1 more source